ADA Scientific Sessions 2025 Abstract
Continuous Protein Sensor for Sarcopenia Management during GLP-1RA Therapy
The paper
San Diego
ADA Scientific Sessions 2025 Abstract, 20 Jun 2025
Presented at ADA Scientific Sessions 2025, late-breaking 2041-LB
Related
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
